Quick Answer
Evogene Ltd. reported Total Assets of $20.05 million for the year ending 2025.
- Evogene Ltd. showed a decrease of -49.7% in Total Assets from 2024 to 2025.
- This data is from Evogene Ltd.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), Evogene Ltd.'s Total Assets has declined by 79.1%.
- Historical annual values: Fiscal year 2025: $20.05 million | Fiscal year 2024: $39.86 million | Fiscal year 2023: $51.10 million | Fiscal year 2022: $56.13 million | Fiscal year 2021: $76.30 million | Fiscal year 2020: $71.92 million | Fiscal year 2019: $71.36 million | Fiscal year 2018: $58.69 million | Fiscal year 2017: $77.60 million | Fiscal year 2016: $95.99 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: